Lamattina John L is a director of Ligand Pharmaceuticals, Inc. - Ordinary Shares.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
LIGAND PHARMACEUTICALS INC
13 Jun 23
4
Immunome Inc.
12 Jun 23
4
Immunome Inc.
17 Jan 23
4
LIGAND PHARMACEUTICALS INC
27 Dec 22
4
Immunome Inc.
21 Jun 22
4
LIGAND PHARMACEUTICALS INC
13 Jun 22
4
LIGAND PHARMACEUTICALS INC
17 Nov 21
4
LIGAND PHARMACEUTICALS INC
7 Jun 21
4
Immunome Inc.
1 Jun 21
4
Immunome Inc.
26 May 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
9 Jun 23 | LGND Ligand Pharmaceuticals, Inc. - Ordinary Shares | Common Stock | Grant | Acquire A | No | No | 0 | 1,142 | 0.00 | 28,263 |
9 Jun 23 | LGND Ligand Pharmaceuticals, Inc. - Ordinary Shares | NQSO Common Stock | Grant | Acquire A | No | No | 73.76 | 5,461 | 402.80 k | 5,461 |
8 Jun 23 | IMNM Immunome | Stock Option Common Stock | Grant | Acquire A | No | No | 4.84 | 6,500 | 31.46 k | 6,500 |
15 Jan 23 | IMNM Immunome | Common Stock | Grant | Acquire A | No | No | 4 | 15,125 | 60.50 k | 66,953 |
22 Dec 22 | LGND Ligand Pharmaceuticals, Inc. - Ordinary Shares | NQSO Common Stock | Grant | Acquire A | No | No | 67.03 | 4,484 | 300.56 k | 4,484 |